Post-Market Clinical Follow-Up of STRATAFIX™ Spiral PDS™ PLUS
A Prospective, Multicenter, Multispecialty Evaluation of STRATAFIX™ Spiral PDS™ Plus Knotless Tissue Control Devices in Robotic Procedures
1 other identifier
observational
161
3 countries
8
Brief Summary
This single-arm, prospective, observational multicenter study will collect clinical data in a post-market setting across two different specialties in Robotic surgical procedures: Bariatric Sleeve gastrectomy (Staple line reinforcement) and Hysterectomy (Vaginal cuff closure). Investigators will perform the procedure using SFX Spiral PDS Plus in compliance with their standard surgical approach and the IFU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2019
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2019
CompletedFirst Posted
Study publicly available on registry
May 3, 2019
CompletedStudy Start
First participant enrolled
December 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 13, 2023
CompletedFebruary 17, 2026
February 1, 2026
3.4 years
April 26, 2019
February 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of subjects with no bleeding or mild bleeding (defined as success) at the completion of the suturing at the organ layer (vaginal cuff closure or gastric staple line reinforcement using STRATAFIX™ Spiral PDS™ Plus).
The bleeding grade assessment used for the primary endpoint will be made right after the suturing is completed. Any re-bleeding after the initial assessment (just before the removal of the optics and trocars) from the suture line after this assessment will be considered a failure for the primary performance endpoint.
Intra-op assessment (During Surgery; after suturing of the target tissue, Day of surgery)
Secondary Outcomes (10)
Qualitative Assessment of Suture Handling
Intra-op (at surgery, after suturing of the target tissue layer, Day of surgery)
Time to Closure (in minutes/seconds)
Intra-op (during suturing of the target tissue, Day of surgery)
Overall procedure time (first incision to skin closure)
Intra-op (during the surgery, Day of surgery)
Length of stay in hours
Post-Operative up to 48 hrs
Estimated intra-operative blood loss per institutional standard of care and incidence of subjects requiring blood transfusion
Intra-Op (during the surgery, Day of surgery)
- +5 more secondary outcomes
Study Arms (1)
Stratafix Arm
The single study arm would comprise of two different specialties in Robotic surgical procedures: Bariatric Sleeve gastrectomy (Staple line reinforcement) and Hysterectomy (Vaginal cuff closure).
Interventions
1. Robotic Bariatric Sleeve gastrectomy 2. Robotic Hysterectomy with or without oophorectomy;
Eligibility Criteria
Subjects ≥ 18 years who are undergoing elective/non-emergent gastric or gynecological procedures robotically
You may qualify if:
- Elect to have a Robotic Bariatric Sleeve Gastrectomy or Robotic Total Hysterectomy where STRATAFIX™ Spiral PDS™ Plus device is used for staple line re-enforcement or vaginal cuff closure, respectively
- Are willing and able to give consent and comply with all study-related evaluations and treatment scheduled
- Subjects are ≥ 18 years of age
You may not qualify if:
- Physical or psychological condition which would impair study participation or are unwilling or unable to participate in all required study visits
- Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of study product
- Enrolled in a concurrent clinical study (drug/device) that might affect current study primary or secondary endpoints
- Allergic to poly (p-dioxanon), IRGACARE®\* MP (triclosan) or D\&C Violet No. 2 colorant
- Pregnant or lactating female subjects as confirmed prior to the procedure
- Subjects undergoing radical hysterectomy (Type B, C and D) according to Querleu \& Morrow classification or gastric sleeve revision surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ethicon, Inc.lead
Study Sites (8)
Baptist Health South Florida
Miami, Florida, 33173, United States
Albany Medical
Albany, New York, 12208, United States
Mt. Sinai
New York, New York, 10029, United States
Lenox Hill hospital
New York, New York, 10075, United States
Universitaetsklinikum Hamburg Eppendorf
Hamburg, Germany
Klinuk fur Allgemelne, Viszeral-ThoraxTransplantations- und Kinderchirurgie
Kiel, Germany
University of Naples
Naples, Italy
University Pisa
Pisa, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2019
First Posted
May 3, 2019
Study Start
December 11, 2019
Primary Completion
May 10, 2023
Study Completion
November 13, 2023
Last Updated
February 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
Johnson \& Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu